We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current WGS market cap is 2.2B. The company's latest EPS is USD -6.3982 and P/E is -12.43.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 53.3M | 57.42M | 62.42M | 70.51M | 76.87M |
| Operating Income | -34.35M | -37.75M | -13.66M | -10.58M | -7.78M |
| Net Income | -43.32M | -24.74M | -20.24M | -29.17M | -8.31M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 212.2M | 234.69M | 202.57M |
| Operating Income | -206k | -446.15M | -457.51M | -182.3M |
| Net Income | -192k | -245.39M | -548.98M | -175.77M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 417.29M | 418.76M | 394.53M | 389.1M | 408.84M |
| Total Liabilities | 163.03M | 190.74M | 187.31M | 195.06M | 204.34M |
| Total Equity | 254.26M | 228.02M | 207.22M | 194.04M | 204.5M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 444.14M | 554.09M | 490.94M | 418.76M |
| Total Liabilities | 15.59M | 165.99M | 237.24M | 190.74M |
| Total Equity | 5M | 388.1M | 253.71M | 228.02M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -150.29M | -180.15M | -16.41M | -20.92M | -25.31M |
| Investing | -38.86M | -43.73M | 843k | -21.86M | -29.61M |
| Financing | 139.14M | 186.24M | -438k | -829k | 13.14M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -386k | -190.43M | -319.16M | -180.15M |
| Investing | -442.75M | -20.79M | -141.33M | -43.73M |
| Financing | 444.23M | 493.73M | 197.32M | 186.24M |
| Market Cap | 2.2B |
| Price to Earnings Ratio | -12.43 |
| Price to Sales Ratio | 10.79 |
| Price to Cash Ratio | 21.93 |
| Price to Book Ratio | 9.59 |
| Dividend Yield | - |
| Shares Outstanding | 27.47M |
| Average Volume (1 week) | 404.09k |
| Average Volume (1 Month) | 514.77k |
| 52 Week Change | 2,540.26% |
| 52 Week High | 89.1099 |
| 52 Week Low | 2.466 |
| Spread (Intraday) | 2 (2.44%) |
| Company Name | GeneDx Holdings Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.genedx.com |
| Industry | health services (8000) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
